1) Liu W, Tang F, Fontanet A, Zhan L, Wang TB, Zhang PH, Luan YH, Cao CY, Zhao QM, Wu XM, Xin ZT, Zuo SQ, Baril L, Vabret A, Shao YM, Yang H, Cao WC. Molecular epidemiology of severe acute respiratory syndrome–associated coronavirus in a patient cluster from Beijing. Emerg Infect Dis, 2005;11:1420-4. Abstract

2) Arafa N, El Hoseiny M, Rekacewicz C, Bakr I, El-Kafrawy S, El Daly M, Aoun S, Marzouk D, Mohamed MK, Fontanet A. Changing pattern of HCV spread in rural areas of Egypt. J Hepatol 2005;43:418-24. Abstract

3) Lortholary O, Fontanet A, Mémain N, Martin A, Sitbon K, Dromer F for the French Cryptococcosis Study Group. Incidence and risk factors of immune reconstitution inflammatory syndrome in the course of cryptococcosis in HIV-infected patients receiving HAART: a multicenter study in France. AIDS, 2005;19:1043-9. Abstract

4) El Gaafary M, Rekacewicz C, Abdel-Rahman AG, Allam MF, El Hosseiny M, Abdel Hamid M, Colombani F, Sultan Y, El-Aidy S, Fontanet A, Mohamed MK. Surveillance of acute hepatitis C in Cairo, Egypt. J Med Virol, 2005;76:520-5. Abstract

5) Abuye C, Tsegaye A, West CE, Versloot P, Sanders EJ, Wolday D, Hamann D, De Wit TF, Fontanet AL. Determinants of CD4 counts among HIV-negative Ethiopians: role of body mass index, gender, cigarette smoking, khat (Catha Edulis) chewing, and possibly altitude? J Clin Immunol. 2005;25:127-33. Abstract

6) Song HD, Tu CC, Zhang GW, Wang SY, Zheng K, Lei LC, Chen QX, Gao YW, Zhou HQ, Xiang H, Zheng HJ, Chern SW, Cheng F, Pan CM, Xuan H, Chen SJ, Luo HM, Zhou DH, Liu YF, He JF, Qin PZ, Li LH, Ren YQ, Liang WJ, Yu YD, Anderson L, Wang M, Xu RH, Wu XW, Zheng HY, Chen JD, Liang G, Gao Y, Liao M, Fang L, Jiang LY, Li H, Chen F, Di B, He LJ, Lin JY, Tong S, Kong X, Du L, Hao P, Tang H, Bernini A, Yu XJ, Spiga O, Guo ZM, Pan HY, He WZ, Manuguerra JC, Fontanet A, Danchin A, Niccolai N, Li YX, Wu CI, Zhao GP. Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc Natl Acad Sci U S A. 2005;102:2430-5. Abstract

7) Fontanet AL, Houzé S, Keundjian A, Schiemann R, Ralaimazava P, Durand R, Cha O, Coulaud JP, Le Bras J, Bouchaud O. Efficacy of anti-malarial chemoprophylaxis among French residents traveling to Africa. Trans Roy Soc Trop Med Hyg, 2005;99:91-100. Abstract

8) Vray M, Hamelin B, Jaillon P; Round Table No.2, Giens XX. The respective roles of controlled clinical trials and cohort monitoring studies in the pre- and postmarketing assessment of drugs. Therapie. 2005; 60:339-44, 345-9. Abstract

9) Lombart JP, Vray M, Kafando A, Lemee V, Ouedraogo-Traore R, Corrigan GE, Plantier JC, Simon F, Braun J. Plasma virion reverse transcriptase activity and heat dissociation-boosted p24 assay for HIV load in Burkina Faso, West Africa. AIDS. 2005;19:1273-7. Abstract

10) Vray M, Joubert JM, Eschwege E, Liard F, Fagnani F, Montestruc F, Fages S, Begaud B. Results from the observational study EPIGRAM: management of excess weight in general practice and follow-up of patients treated with orlistat. Therapie. 2005; 60:17-24. Abstract

11) Tubiana R, Carcelain G, Vray M, Gourlain K, Dalban C, Chermak A, Rabian C, Vittecoq D, Simon A, Bouvet E, El Habib R, Costagliola D, Calvez V, Autran B, Katlama C; for the Vacciter Study group. Therapeutic immunization with a human immunodeficiency virus (HIV) type 1-recombinant canarypox vaccine in chronically HIV-infected patients: The Vacciter Study (ANRS 094). Vaccine. 2005;23:4292-301. Abstract

12) Guimier JM, Candau D, Garenne M, Teulieres L. Measuring drug affordability (Senegal)]. Sante. 2005;15:53-62. Abstract

13) Guimier JM, Candau D, Garenne M, Teulieres L. [Why drug prices are high in sub-Saharan Africa. Analysis of price structure: the case of Senegal] Sante. 2005;15:41-52. Abstract

14) Mekonnen Y, Sanders E, Messele T, Wolday D, Dorigo-Zestma W, Schaap A, Mekonnen W, Meless H, Mihret W, Fontanet A, Coutinho RA, Dukers NH. Prevalence and incidence of, and risk factors for, HIV-1 infection among factory workers in Ethiopia, 1997-2001. J Health Popul Nutr. 2005;23:358-68. Abstract

Mis à jour le 10/06/2014


Unité d'Epidémiologie des Maladies Emergentes

Institut Pasteur
25-28 rue du Dr Roux
75724 Paris Cedex 15

Tél : +33 (0)1 40 61 37 66
Fax: +33 (0)1 45 68 88 76

Où nous trouver ?